| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Telomir Pharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 101,134 | $627,031 | $6.20 | 08 Feb 2024 | Direct |
| RENOVARO INC. | Chief Financial Officer | Option to purchase shares of common stock | 250,000 | 21 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RENB | RENOVARO INC. | 21 Jan 2025 | 1 | $0 | 4 | Chief Financial Officer | 25 Feb 2025, 13:29 |
| RENB | RENOVARO INC. | 06 Jan 2025 | 0 | $0 | 3 | Chief Financial Officer | 13 Jan 2025, 16:17 |
| TELO | Telomir Pharmaceuticals, Inc. | 08 Feb 2024 | 0 | $0 | 3 | Chief Financial Officer | 08 Feb 2024, 17:55 |